BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 601092)

  • 21. Approaches to the control and prevention of Tay-Sachs disease.
    Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
    Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Doubtful benefits of Tay-Sachs screening.
    Kuhr MD
    N Engl J Med; 1975 Feb; 292(7):371. PubMed ID: 1117969
    [No Abstract]   [Full Text] [Related]  

  • 23. Tay-Sachs heterozygote screening: specificity and sensitivity.
    Scriver CR; Gold RJ
    Prog Clin Biol Res; 1977; 18():239-43. PubMed ID: 601079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory methods and quality control in the Toronto Tay-Sachs program.
    Lowden JA; Skomorowski MA; Howard F
    Prog Clin Biol Res; 1977; 18():221-6. PubMed ID: 601078
    [No Abstract]   [Full Text] [Related]  

  • 25. Community screening for Tay-Sachs disease.
    Jackson LG; Nimoityn P; Faust HS; Glazerman LR
    Am Fam Physician; 1976 Apr; 13(4):111-4. PubMed ID: 1266700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Voluntary mass screening program for Tay-Sachs disease in Israel].
    Padeh B; Shahar S; Navon R; Modan M; Goldman B
    Harefuah; 1977 Jun; 92(11):481-5. PubMed ID: 885382
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening programs for Tay-Sachs disease in North Carolina.
    Rivin BE; Slome C
    N C Med J; 1977 Nov; 38(11):649-51. PubMed ID: 270612
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of the physician in screening for carriers of Tay-Sachs disease.
    Lowden JA
    Can Med Assoc J; 1978 Sep; 119(6):575-8. PubMed ID: 709448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of utilization of Tay-Sachs screening.
    Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
    Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advocacy and compliance in genetic screening. Behavior of physicians and clients in a voluntary program of testing for the Tay-Sachs gene.
    Beck E; Blaichman S; Scriver CR; Clow CL
    N Engl J Med; 1974 Nov; 291(22):1166-70. PubMed ID: 4418237
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Possible hazards in screening of adolescents for Tay-Sachs disease.
    Stone MH
    N Engl J Med; 1976 Jul; 295(2):113. PubMed ID: 1272314
    [No Abstract]   [Full Text] [Related]  

  • 32. The National Tay-Sachs and Allied Diseases Association, Inc.
    Saperstein J
    Prog Clin Biol Res; 1977; 18():9-10. PubMed ID: 601099
    [No Abstract]   [Full Text] [Related]  

  • 33. Social aspects of genetic screening for Tay-Sachs disease: the pilot community screening program in Baltimore and Washington.
    McQueen DV
    Soc Biol; 1975; 22(2):125-33. PubMed ID: 1198132
    [No Abstract]   [Full Text] [Related]  

  • 34. Some influences on public participation in a genetic screening program.
    Becker MH; Kaback MM; Rosenstock IM; Ruth MV
    J Community Health; 1975; 1(1):3-14. PubMed ID: 1228204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Screening for Tay-Sachs disease.
    Evans PR; Ellis RB
    Lancet; 1974 Mar; 1(7857):575-6. PubMed ID: 4132029
    [No Abstract]   [Full Text] [Related]  

  • 36. Community-based genetic education, communication channels, and knowledge of Tay-Sachs disease.
    Massarik F; Kaback MM; Greenwald S; Nathan TJ; Rosenthal M; Bass DM
    Prog Clin Biol Res; 1977; 18():353-66. PubMed ID: 601086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tay-Sachs and related storage diseases: family planning.
    Schneiderman G; Lowden JA; Rae-Grant Q
    Ment Retard; 1978 Feb; 16(1):13-5. PubMed ID: 415210
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Zeesman S; Clow CL; Cartier L; Scriver CR
    Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.